WHISTLE BLOWER: Hundreds of dying patients removed from remdesivir trial to make drug look better

In this interview from Steve Kirsch with nurses from America's Frontline Nurses, Nicole Sirotek says that she personally watched hundreds of deadly ill patients being removed from the clinical trial on using remdesivir as treatment for hospitalized COVID patients.

The clinical trial was sponsored by remdesivir's manufacturer Gilead, which has earned countless billions from a highly toxic drug that is extremely old and cheap to make, but is sold for approximately $3000 per treatment course.

Of course Gilead has a huge incentive to make the drug look as safe and effective as possible. Removing dying patients from the treatment group seems to be one of the ways they achieved this marketing feat.

The other nurses say that each and every clinical trial sponsored by the manufacturer is rife with fraud. The stakes are simply too high.

"The main reason we take so many drugs is that drug companies don't sell drugs, they sell lies about drugs." ― Peter Gøtzsche

The scientific article of the trial that nurse Nicole Sirotek mentions can be found here:

Remdesivir for the Treatment of Covid-19 — Final Report
https://www.nejm.org/doi/full/10.1056/NEJMoa2007764

A preliminary version of this article was published on May 22, 2020, at NEJM.org.

The above information shows that the correct name for RCT is not RANDOMIZED Controlled Trial, but RESULTS Controlled Trial. Big Pharmaffia is a term that the pharmaceutical companies have duly earned.

The sponsors of the trial start out with a certain goal, e.g. to make a profitable drug look safe and effective, or to make an unprofitable drug (that competes with highly profitable drugs) look unsafe and/or ineffective.

Then the trial is designed and executed in such a way that the desired outcome magically appears. Trial design parameters that can be used are for instance timing of the intervention, dosing, duration of treatment, treatment group, et cetera.

During the execution phase they also have many parameters. For instance, during the trials for AZT as treatment for AIDS in the 1980's, patients on AZT were quickly becoming extremely ill due to the medicine, but were kept alive with multiple blood transfusions. This was not mentioned in the scientific publication. Also, the control group did not get the transfusions.

After the trial has finished, the sponsors have more tools at their disposal, such as statistical tricks to get the outcomes they want. In the remdesivir trial, they changed the trials' outcomes during the trial, when it become clear that remdesivir would not perform positively on the original outcomes. The FDA has strict rules on this kind of scientific manipulation, but chose not to enforce.

The nurses in this case are not only blowing the whistle on fraud during clinical trials, but also on all the agencies (such as NIH, FDA, CDC) being captured by the pharmaceutical companies. In reality the agencies are not there for public health, but they're basically the marketing arm for the pharmaceutical companies.

Their goal is to maximize sales of highly profitable drugs and minimize the use of cheap competitors. The organizations may employ well-meaning people, but these would have to be willfully ignorant about what is really going on.

When a whistle blower contacts watch dog FDA to disclose fraud, instead of doing further research, the FDA passes the information on to the whistle blower's employer, who will subsequently fire the whistle blower.

REFERENCES

https://www.americanfrontlinenurses.com/

"This isn't a hospital, it's a concentration camp": Nurse Nicole Sirotek on abominable U.S. care
https://rumble.com/vt7oyr-this-isnt-a-hospital-its-a-concentration-camp-nurse-nicole-sirotek-on-abomi.html

SOURCE

Watch the whole 2 hour interview here:
https://rumble.com/vsqovk-five-nurses-speak-out-about-what-is-really-going-on-in-hospitals.html

This segment starts at 27m55s.